António de Almeida

Professor Catedrático

Bio

Participação na FM-UCP

  • Diretor da Faculdade 
  • Mentor 

Áreas de Atividade

Hematologia Clínica | Anemia | Neoplasias Mieloides Crónicas | Epigenética | Educação Médica

Atividade Profissional

  • Faculdade de Medicina da Universidade Católica (FM-UCP) 
  • Centro de Investigação Interdisciplinar em Saúde (CIIS) – Plataforma CatólicaMed
  • Hospital da Luz Lisboa   

Formação

  • Universitdade: University of Cambridge 
  • Junho 1990: BA Hons (Cantab) 
  • Medical School: Addenbrooke's Hospital, Cambridge 
  • Dezembro 1993: MB Bchir (Cantab) 

Qualificações Pós-Graduação

  • Fevereiro 1997: MRCP (Lond) 
  • Setembro 2001: MRCPath 
  • Junho 2002: Certificado de conclusão de formação especializada (CCST) em Hematologia 
  • Maio 2007: PhD Imperial College 
  • Maio 2015: Consultor em Hematologia na Ordem dos Médicos 
  • Maio 2021: Agregação à Universidade Católica Portuguesa  

Resumo da Carreira Profissional

  • Janeiro 1993 – Set 1997: Interno geral, Cambridge e St George’s Hospital Londres
  • Setembro 1997 – Jun 2003: Interno especialidade hematologia Hospitais zona Norte de Londres (Hammersmith, Royal Free, Great Ormond Street, St Mary’s, Central Middlesex) 
  • Junho 2003 - Jun 2006: Leukaemia Research Fund Clinical Research Fellow 
  • Setembro 2006 – set 2017: Hematologista IPO Lisboa 
  • Setembro 2017 - Presente: Diretor de serviço de Hematologia, Hospital da Luz Lisboa 
  • Março 2021 - Presente: Diretor da Faculdade de Medicina da UCP 

Línguas

Português | Inglês | Italiano | Espanhol | Francês

Outros Interesses

  • O mais feliz no mar: barco ou surf 
  • Uso golf para estragar um bom passeio 
  • Fascínio por pássaros 
  • Boa comida e bebida 

 

Artigo

Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT

António de Almeida (with Carmelo Gurnari). 2025. Blood
Artigo

Determining treatment pathways for older patients with acute myeloid leukemia

António de Almeida (with Esther N. Oliva). 2025. Expert Review of Hematology
Artigo

European guidelines on treatment and supportive measures in chronic neutropenias

António de Almeida (with Francesca Fioredda). 2025. HemaSphere
Artigo

Fitness assessment in acute myeloid leukemia

António de Almeida (with Adriano Venditti). 2025. Blood advances
Artigo

Genetic variants in oxidative stress-related genes and their impact on prognosis and treatment response in chronic myeloid leukemia patients

António de Almeida (with Raquel Alves). 2025. International Journal of Molecular Sciences
Artigo

European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission

António de Almeida (with Francois-Xavier Mahon). 2024. Journal of Clinical Oncology
Artigo

Exploring the inflammatory profile of homelessness population

António de Almeida (with Ana T. P. C. Gomes). 2024. Frontiers in Public Health
Artigo

Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors

António de Almeida (with Fabio Efficace). 2024. Leukemia
Artigo

Immune-monitoring of myelodysplastic neoplasms

Bruno António Caetano Cardoso & António de Almeida (with i4MDS consortium). 2024. HemaSphere
Outras

Precision hematology

António de Almeida (with EHA Board). 2024. HemaSphere
Artigo

Targeting the bone marrow niche, moving towards leukemia eradication

Bruno António Caetano Cardoso & António de Almeida (with Semedo, Carla). 2024. Frontiers in Hematology
Outras

Therapeutic resistance in myeloproliferative neoplasms

António de Almeida (with Carla Semedo). 2024. 6th ASPIC International Congress, Faro, Portugal, 29/04/24
Outras

A lack of diversity, equity, and inclusion in clinical research has direct impact on patient care

António de Almeida (with Tarec Christoffer El-Galaly). 2023. HemaSphere
Outras

Diagnosis and risk prevention of Covid 19 in homeless people in Lisbon

António de Almeida (with Amélia Simões Figueiredo). 2023. BMC Proceedings
Artigo

The European guidelines on diagnosis and management of neutropenia in adults and children

António de Almeida (with Francesca Fioredda). 2023. HemaSphere
Artigo

The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action

António de Almeida (with Fioredda, Francesca). 2023. HemaSphere
Livro

Unravelling neurosciences today

António de Almeida (with Ana Mineiro). 2023. Estudos em Homenagem
Artigo

Combination of Elacridar with Imatinib Modulates Resistance Associated with Drug Efflux Transporters in Chronic Myeloid Leukemia

António de Almeida (with Alves, Raquel). 2022. Biomedicines
Artigo

Genetic Variants of ABC and SLC Transporter Genes and Chronic Myeloid Leukaemia: Impact on Susceptibility and Prognosis

António de Almeida (with Alves, Raquel). 2022. International Journal of Molecular Sciences
Outras

How a medical association can make a difference in a crisis situation

António de Almeida (with Nathalie Van Havre). 2022. HemaSphere
Artigo

The progress test of the European Hematology Association

António de Almeida (with Marielle J. Wondergem). 2022. HemaSphere
Artigo

The Progress Test of the European Hematology Association: A New Tool for Continuous Learning

António de Almeida (with Wondergem, Marielle J.). 2022. HemaSphere
Outras

American Society of Hematology 2020 podcast collection

António de Almeida (with António Almeida). 2021. Advances in Therapy
Artigo

Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study

António de Almeida (with Ludovic Lhermitte). 2021. Modern Pathology
Outras

Final analysis of a PAN European STOP tyrosine kinase inhibitor trial in chronic myeloid leukemia

António de Almeida (with Francois-Xavier Mahon). 2021. Blood
Artigo

Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study

António de Almeida (with Lisa Pleyer). 2021. The Lancet Haematology
Artigo

Phase III, randomized, placebo-controlled trial of CC-486 (Oral Azacitidine) in patients with lower-risk myelodysplastic syndromes

António de Almeida (with Guillermo Garcia-Manero). 2021. Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Artigo

Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes

António de Almeida (with Guillermo Garcia-Manero). 2021. Journal of Clinical Oncology
Artigo

Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance

António de Almeida (with Raquel Alves). 2021. Cancers
Artigo

Spontaneous Tumor Lysis Syndrome: A Rare Presentation in Plasmablastic Lymphoma

António de Almeida (with Joana Infante). 2021. Journal of Hematology
Artigo

The Activation of Endothelial Cells Relies on a Ferroptosis-Like Mechanism: Novel Perspectives in Management of Angiogenesis and Cancer Therapy

António de Almeida (with Filipa Lopes-Coelho). 2021. Frontiers in Oncology
Artigo

Toxic iron species in lower-risk myelodysplastic syndrome patients

António de Almeida (with the EUMDS Registry Participants). 2021. Leukemia
Artigo

Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levels.

António de Almeida 2020. Leukemia & lymphoma
Artigo

Congenital and acquired chronic neutropenias

António de Almeida (with Helen A. Papadaki). 2020. HemaSphere
Artigo

Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-α

António de Almeida (with Raquel Alves). 2020. Journal of Translational Medicine
Artigo

Guideline-based indicators for adult patients with myelodysplastic syndromes.

António de Almeida 2020. Blood advances
Artigo

Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes

António de Almeida (with EUMDS Registry Participants). 2020. Haematologica
Artigo

Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients.

António de Almeida 2020. Leukemia
Artigo

Monocytes as Endothelial Progenitor Cells (EPCs), Another Brick in the Wall to Disentangle Tumor Angiogenesis.

António de Almeida 2020. Cells
Artigo

Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective

António de Almeida (with Theo De Witte). 2020. Haematologica
Artigo

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.

António de Almeida 2020. The New England journal of medicine
Artigo

Clinical benefit-risk profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q)

António de Almeida (with Guillermo Garcia-Manero). 2019. Clinical Lymphoma, Myeloma and Leukemia
Artigo

Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial

António de Almeida (with Guillermo Garcia-Manero). 2019. Clinical Lymphoma Myeloma and Leukemia
Outras

Effects of the therapeutic armamentarium on survival and time to next treatment in CMML subtypes

António de Almeida (with Lisa Pleyer). 2019. Blood
Artigo

Everolimus in combination with Imatinib overcomes resistance in Chronic myeloid leukaemia.

António de Almeida 2019. Medical oncology (Northwood, London, England)
Outras

Genetic variability of influx and efflux transporters

António de Almeida (with Raquel Alves). 2019. European Journal of Clinical Investigation
Outras

I-care for MDS

António de Almeida (with Kristina Stojkov). 2019. Blood
Artigo

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry.

António de Almeida 2019. Haematologica
Artigo

Less iron improves MDS haematopoiesis.

António de Almeida 2019. British journal of haematology
Artigo

MicroRNA signature refine response prediction in CML

António de Almeida (with Raquel Alves). 2019. Scientific Reports
Artigo

Negative MR<sup>4·0</sup> chronic myeloid leukaemia and its possible implications for treatment-free remission.

António de Almeida 2019. British journal of haematology
Artigo

New prospects for the management of cardiovascular effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.

António de Almeida 2019. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
Artigo

Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatme...

António de Almeida 2019. Leukemia & lymphoma
Artigo

The European hematology exam

António de Almeida (with José Tomás Navarro). 2019. HemaSphere
Artigo

Treatment of anemia in transfusion-dependent and non-transfusion-dependent lower-risk MDS

António de Almeida (with Ulrich Germing). 2019. HemaSphere
Artigo

Vorinostat synergizes with antioxidant therapy to target myeloproliferative neoplasms

António de Almeida & Bruno António Caetano Cardoso (with Cardoso, B.A.). 2019. Experimental Hematology
Artigo

Considerations for treatment-free remission in patients with chronic myeloid leukemia

António de Almeida (with Giuseppe Saglio). 2018. Clinical Lymphoma, Myeloma and Leukemia
Artigo

Considerations for Treatment-free Remission in Patients With Chronic Myeloid Leukemia: A Joint Patient–Physician Perspective

António de Almeida (with Giuseppe Saglio). 2018. Clinical Lymphoma Myeloma and Leukemia
Artigo

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI)

António de Almeida (with EURO-SKI investigators). 2018. The Lancet Oncology
Artigo

Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes.

António de Almeida 2018. Blood advances
Artigo

Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia.

António de Almeida 2018. Blood advances
Artigo

Evidence-Based Criteria for Tyrosine Kinase Inhibitor Interruption in Pregnancy.

António de Almeida 2018. Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Artigo

Hematology traning in Europe

António de Almeida (with A. Almeida). 2018. International Journal of Laboratory Hematology
Artigo

Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS

António de Almeida (with Louise de Swart). 2018. Leukemia Research
Artigo

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score

António de Almeida (with for the European ALMA + Investigators). 2018. Leukemia and Lymphoma
Artigo

Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q)

António de Almeida (with António Almeida). 2018. Leukemia and Lymphoma
Outras

Should more MDS patients be treated with immune-suppression?

António de Almeida (with António Almeida). 2018. Leukemia Research
Artigo

The effect of lenalidomide on health-related quality of life in patients with lower-risk Non-del(5q) myelodysplastic syndromes

António de Almeida (with Valeria Santini). 2018. Clinical Lymphoma, Myeloma and Leukemia
Artigo

The European hematology curriculum

António de Almeida (with A. M. Almeida). 2018. HemaSphere
Artigo

Clinical benefit of eculizumab in patients with no transfusion history in the International Paroxysmal Nocturnal Haemoglobinuria Registry

António de Almeida (with António M. Almeida). 2017. Internal Medicine Journal
Artigo

Clinical outcomes of 217 patients with acute erythroleukemia according to treatment type and line

António de Almeida (with António M. Almeida). 2017. International Journal of Molecular Sciences
Artigo

Clinical outcomes of 217 patients with acute erythroleukemia according to treatment type and line: A retrospective multinational study

António de Almeida (with Almeida, A.M.). 2017. International Journal of Molecular Sciences
Artigo

Clinical outcomes of AML patients treated with Azacitidine in Portugal

António de Almeida (with António Almeida). 2017. Leukemia Research Reports
Artigo

Clinical outcomes of AML patients treated with Azacitidine in Portugal: A retrospective multicenter study

António de Almeida (with Almeida, A.). 2017. Leukemia Research Reports
Artigo

Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients

António de Almeida (with Álvaro Urbano-Ispizua). 2017. Haematologica
Artigo

HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms

António de Almeida (with Teresa L. Ramos). 2017. Oncotarget
Artigo

HDAC8 overexpression in mesenchymal stromal cells from JAK2<sup>+</sup>myeloproliferative neoplasms: A new therapeutic target?

António de Almeida (with Ramos, T.L.). 2017. Oncotarget
Artigo

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+)

António de Almeida (with Falantes, J.). 2017. Leukemia and Lymphoma
Artigo

Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)

António de Almeida (with António Almeida). 2017. Leukemia Research
Artigo

Acute myeloid leukemia in the older adults

António de Almeida (with António M. Almeida). 2016. Leukemia Research Reports
Artigo

Design and rationale of the QUAZAR lower-risk MDS (AZA-MDS-003) trial

António de Almeida (with Guillermo Garcia-Manero). 2016. BMC Hematology
Artigo

Design and rationale of the QUAZAR lower-risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes a...

António de Almeida (with Garcia-Manero, G.). 2016. BMC Hematology
Artigo

Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia

António de Almeida (with Gail J. Roboz). 2016. Future Oncology
Artigo

Randomized phase III study of lenalidomide versus placebo in RBC transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes and ineligible for or refractory to erythropoiesis-stimulating agents

António de Almeida (with Valeria Santini). 2016. Journal of Clinical Oncology
Artigo

Epigenetic alterations in fanconi anaemia

António de Almeida (with Hélio Belo). 2015. PLoS one
Artigo

Epigenetic Alterations in Fanconi anaemia: Role in pathophysiology and therapeutic potential

António de Almeida & Bruno António Caetano Cardoso (with Belo, H.). 2015. PLoS ONE
Artigo

The bone marrow-mediated protection of myeloproliferative neoplastic cells to vorinostat and ruxolitinib relies on the activation of JNK and PI3K Signalling Pathways

António de Almeida & Bruno António Caetano Cardoso (with Cardoso, B.A.). 2015. PLoS ONE
Artigo

Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes

António de Almeida (with Louise de Swart). 2015. British Journal of Haematology
Artigo

Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry

António de Almeida (with de Swart, L.). 2015. British Journal of Haematology
Artigo

Cell-type-specific transcriptional regulation of PIGM underpins the divergent hematologic phenotype in inherited GPl deficiency

António de Almeida (with Joana R. Costa). 2014. Blood
Outras

Optimizing treatments in rare diseases

António de Almeida (with António M. Almeida). 2014. Leukemia Research
Artigo

Optimizing treatments in rare diseases: Will our evidence come from registry data?

António de Almeida (with Almeida, A.M.). 2014. Leukemia Research
Outras

Survey of professional competence in hematology in Europe

António de Almeida (with Eva Hellström Lindberg). 2014. Haematologica
Artigo

Efficacy and tolerability of 5-day azacytidine dose-intensified regimen in higher-risk MDS

António de Almeida (with Francesca Pierdomenico). 2013. Annals of Hematology
Outras

Modifying disease in CMML

António de Almeida (with António Almeida). 2013. Leukemia Research
Artigo

Modifying disease in CMML: Who responds to Azacitidine?

António de Almeida (with Almeida, A.). 2013. Leukemia Research
Artigo

Treatment of acute erythroleukemia with azacitidine

António de Almeida (with Francesca Pierdomenico). 2013. Leukemia Research Reports
Artigo

Treatment of acute erythroleukemia with Azacitidine: A case series

António de Almeida (with Pierdomenico, F.). 2013. Leukemia Research Reports
Artigo

Vorinostat induces apoptosis and differentiation in myeloid malignancies

António de Almeida (with Gabriela Silva). 2013. PLoS one
Artigo

Vorinostat Induces Apoptosis and Differentiation in Myeloid Malignancies: Genetic and Molecular Mechanisms

António de Almeida & Bruno António Caetano Cardoso (with Silva, G.). 2013. PLoS ONE
Artigo

Generalized skin reactions in patients with MDS and CMML treated with azacitidine

António de Almeida (with António M. Almeida). 2012. Leukemia Research
Artigo

Generalized skin reactions in patients with MDS and CMML treated with azacitidine: Effective management with concomitant prednisolone

António de Almeida (with Almeida, A.M.). 2012. Leukemia Research
Artigo

Treatment of chronic myelomonocytic leukemia with 5-Azacitidine

António de Almeida (with Michael Thorpe). 2012. Leukemia Research
Artigo

Treatment of chronic myelomonocytic leukemia with 5-Azacitidine: A case series and literature review

António de Almeida (with Thorpe, M.). 2012. Leukemia Research
Artigo

Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox

António de Almeida (with Florian Nolte). 2011. Leukemia Research
Artigo

Chapter 16 Inherited GPI deficiency

António de Almeida (with Almeida, A.). 2009. Enzymes
Artigo

Chapter 16 Inherited GPI deficiency

António de Almeida (with António Almeida). 2009. The Enzymes
Outras

Controlo transcricional de PIGM:mecanismo de expressão diferencial em células sanguíneas na insuficiência hereditária de GPI

António de Almeida (with Nolasco, Madalena Tavares Festas de Sousa). 2009.
Artigo

Inherited glycosylphosphatidyl inositol deficiency

António de Almeida (with António Almeida). 2009. Biochimica et Biophysica Acta - Molecular Basis of Disease
Artigo

Inherited glycosylphosphatidyl inositol deficiency: A treatable CDG

António de Almeida (with Almeida, A.). 2009. Biochimica et Biophysica Acta - Molecular Basis of Disease
Artigo

Recomendações para o diagnóstico, tratamento e monitorização da leucemia mielóide crónica

António de Almeida (with António Almeida). 2009. Acta Medica Portuguesa
Artigo

Recommendations for diagnosis, treatment and monitoring of chronic myeloid leukemia | Recomendações para o diagnóstico, tratamento e monitorização da leucemia mielóide crónica

António de Almeida (with Almeida, A.). 2009. Acta Medica Portuguesa
Artigo

Targeted therapy for inherited GPI deficiency

António de Almeida (with António M. Almeida). 2007. New England Journal of Medicine
Artigo

Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency

António de Almeida (with António M. Almeida). 2006. Nature Medicine
Artigo

Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells

António de Almeida (with Ioannis Kotsianidis). 2006. Blood
Artigo

Bone involvement in sickle cell disease

António de Almeida (with António Almeida). 2005. British Journal of Haematology
Artigo

Human invariant NKT cells are required for effective in vitro alloresponses

António de Almeida (with Scott Patterson). 2005. Journal of Immunology
Artigo

Automated computer result reporting for haemoglobinopathy screening

António de Almeida (with Y. Daniel). 2004. Clinical and Laboratory Haematology
Artigo

Neonatal screening for sickle cell disorders

António de Almeida (with Joan S. Henthorn). 2004. British Journal of Haematology
Artigo

The use of recombinant factor VIIa in children with inherited platelet function disorders.

António de Almeida 2003. British journal of haematology
Artigo

Therapeutic challenges in childhood sickle cell disease Part 1

António de Almeida (with Persis J. Amrolia). 2003. British Journal of Haematology
Artigo

Therapeutic challenges in childhood sickle cell disease Part 1: Current and future treatment options

António de Almeida (with Amrolia, P.J.). 2003. British Journal of Haematology
Artigo

Therapeutic challenges in childhood sickle cell disease. Part 2

António de Almeida (with Persis J. Amrolia). 2003. British Journal of Haematology
Artigo

Therapeutic challenges in childhood sickle cell disease. Part 2: A problem-orientated approach

António de Almeida (with Amrolia, P.J.). 2003. British Journal of Haematology
Artigo

Thromboprophylaxis with unmonitored intermediate-dose low molecular weight heparin in pregnancies with a previous arterial or venous thrombotic event

António de Almeida (with Beverley J. Hunt). 2003. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Artigo

Unusual presentation of factor XIII deficiency

António de Almeida (with A. Almeida). 2002. Haemophilia
Artigo

Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation

António de Almeida (with M. McCloy). 2001. British Journal of Haematology
Artigo

Neonatal screening for haemoglobinopathies

António de Almeida (with António M. Almeida). 2001. British Journal of Haematology
Artigo

Neonatal screening for haemoglobinopathies: The results of a 10-year programme in an English Health Region

António de Almeida (with Almeida, A.M.). 2001. British Journal of Haematology